BRCA 1 /2 and / or HRD
2 clinical trials · Condition
◉ Watch BRCA 1 /2 and / or HRD
| Record | Firm | Date |
|---|---|---|
| Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors (NCT07156253) | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 2025-08-26 |
| Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency (NCT02789332) | GBG Forschungs GmbH | 2016-09-01 |
Track BRCA 1 /2 and / or HRD automatically
Every clearance here is in the API, with alerts when new ones post.